Increased expression level of the splicing variant of SIP1 in motor neuron diseases

International Journal of Biochemistry and Cell Biology

Volumn 34, Issue 6, 2002, Pages 699-707

  Aerbajinai, Wulin ^a   Ishihara, Tadayuki ^b   Arahata, Kiichi ^a,c   Tsukahara, Toshifumi ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b Higashisaitama National Hospital   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Amyotrophic lateral sclerosis (ALS); SMN interacting protein 1 (SIP1); Spinal muscular atrophy (SMA); Splicing variant (SIP1 )

Indexed keywords

PROTEIN; PROTEIN SIP1; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BIOGENESIS; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MOTOR NEURON DISEASE; MUSCLE TISSUE; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PROCESSING; SPINAL MUSCULAR ATROPHY; SPLICEOSOME; TISSUE DISTRIBUTION;

ADULT; ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; BASE SEQUENCE; CHROMOSOMES, HUMAN, PAIR 14; CLONING, MOLECULAR; EXONS; FETUS; GENE EXPRESSION; HUMANS; MOLECULAR SEQUENCE DATA; MOTOR NEURON DISEASE; MUSCLE, SKELETAL; NERVE TISSUE PROTEINS; PROTEIN ISOFORMS; RNA-BINDING PROTEINS; TISSUE DISTRIBUTION; VARIATION (GENETICS);

EID: 0036212375     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(01)00150-9     Document Type: Article

References (23)

1. The spinal muscular atrophies
2. Identification and characterization of a spinal muscular atrophy-determining gene
3. Correlation between severity and SMN protein level in spinal muscular atrophy
4. SMN oligomerisation defect correlates with spinal muscular atrophy severity
5. The spinal muscular atrophy disease gene product (SMN) and its associated protein, SIP1, are in a complex with spliceosomal snRNP biogenesis
6. The SMN-SIP1 complex has an essential role in the spliceosomal snRNP biogenesis
7. A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing
8. Clinical features and differential diagnosis of classical motor neuron disease
9. Aberrant RNA splicing in sporadic amyotrophic lateral sclerosis
10. Identification of alternative splicing forms of GLT-1 mRNA in the spinal cord of amyotrophic lateral sclerosis patients
11. Abnormal EAAT2 splicing in amyotrophic lateral sclerosis
12. Aberrant RNA processing in a neurodegenerative disease: The cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis
13. Mutations in the glutamate transporter EAAT2 gene do not cause abnormal EAAT2 transcripts in amyotrophic lateral sclerosis
14. Construction of a novel database containing aberrant splicing mutations of mammalian genes
15. The regulation of splice-site selection, and its role in human disease
16. RNA processing and human disease
17. The splice of life: Alternative splicing and neurological disease
18. Synergistic anti-apoptotic activity between Bcl-2 and SMN implicated in spinal muscular atrophy
19. The role of the SMN gene in proximal spinal muscular atrophy
20. Mechanisms for neuronal degeneration in amyotrophic lateral sclerosis and in models of motor neuron death
21. Bax and Bcl-2 interaction in a transgenic mouse model of familial amyotrophic lateral sclerosis
22. Alternative splicing and programmed cell death